TUBERCULOSIS DRUG DEVELOPMENT:  TUBERCULOSIS TECHNOLOGY TRANSFER SUPPORT

Release Date:  November 18, 1998

RFP AVAILABLE:  NIH-NIAID-DAIDS-99-17

P.T.

National Institute of Allergy and Infectious Diseases

The Opportunistic Infections Research Branch, Therapeutics Research Program,
Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID),
NIH, has a requirement to develop therapies for the treatment of AIDS and
associated opportunistic infections.  The purpose of this RFP is to seek
responsible offers for new tuberculosis drug technology development and transfer
support.  This contract is to serve as a resource for facilitating the
translation of anti-tuberculosis discoveries into candidates for development and
commercialization.

It is anticipated that one cost reimbursement, completion type contract will be
awarded for a period of seven years, beginning approximately August 17, 1999. 
Request for proposal (RFP) NIH-NIAID-DAIDS-99-17 is presently available
electronically and may be accessed through the NIAID Contract Management Branch
(CMB) Home Page by using the following electronic address and instructions:

NIAID/CMB Home Page (via the WWW): Use http://www.niaid.nih.gov/contract to
access the NIAID/CMB Home Page.  Once at the NIAID/CMB Home Page, click on the
"RFPs" link and then click on "RFP NIH-NIAID-DAIDS-99-17." There is one amendment
to the RFP which is dated October 29, 1998.

Please note that the electronic RFP for this acquisition includes only the Work
Statement, Deliverable and Reporting Requirements, Special Requirements and
Mandatory Qualification, if any, the Technical Evaluation Criteria, and the
Proposal Preparation Instructions.  All information required for the submission
of an offer is available via links within the electronic RFP package.  Following
proposal submission and the initial review process, offerors comprising the
competitive range will be requested to provide additional documentation to the
Contracting Officer.

Responses to this RFP will be due on December 15, 1998.  Any  responsible offeror
may submit a proposal, which will be considered by the Government.  This
advertisement does not commit the Government to award a contract.

INQUIRIES

For further information, contact:

Joyce U. Sagami or Paul D. McFarlane
Contracts Management Branch
National Institute of Allergy and Infectious Diseases
6003 Executive Boulevard, Room 3C07, MSC 7610
Bethesda, MD  20892-7610
Telephone:  (301) 496-7118 or (301) 496-0349
FAX:  (301) 402-0972
Email:  js73b@nih.gov  or pm24v@nih.gov

No collect calls will be accepted.

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.